Selecting the Best CyberKnife Treatment Centres in India for Canadian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 24-08-2026

In 24 years of guiding international patients into Indian hospitals, this genuine scarcity is worth understanding clearly. Even as Ontario celebrated bringing this technology to a second Canadian province, the announcement itself confirmed just how limited access had been up to that point, and provincial health authorities elsewhere have subsequently had to formally study whether even a single dedicated unit makes economic sense for their population, a genuine reflection of how narrow and carefully-managed access to this specific technology remains across the country. This pattern reflects the genuine capital cost and specialised infrastructure this technology demands. A CyberKnife system itself represents a multi-million dollar investment, before accounting for the dedicated medical physics staff, treatment planning software, and ongoing maintenance a genuinely functioning programme requires.

Healing Journeys of Canadian Patients

Canadian Patients Share Their Experience

Key Takeaways

• The guide highlights that CyberKnife remains relatively rare in Canada, with access expanding only gradually. The page 1 graphic notes that Ontario's introduction of its first system was described as a milestone, while provinces such as Alberta have formally studied whether even one dedicated unit is economically justified.
• The page 2 chart illustrates the difference in treatment duration: conventional radiotherapy may involve around 30 treatment sessions, while CyberKnife radiosurgery can deliver a comparable effective dose in approximately 5 sessions for appropriate cases. This can make treatment considerably easier for patients travelling from Canada.
• India is presented as an alternative because leading cancer centres use CyberKnife and equivalent stereotactic systems as established, routine treatments, supported by dedicated medical physics teams and established treatment volumes. The guide also highlights real-time tumour tracking, sub-millimetre precision, English-language care and JCI/NABH-accredited hospitals.
• The selection framework gives 55% weighting to the treating team and 45% to the hospital. Team assessment focuses on honest candidacy assessment, a named medical physicist, established treatment volume and outcome data. Hospital assessment includes established experience, multidisciplinary tumour-board review, international accreditation and complete treatment records.
• The page 4 qualification table identifies MD in Radiotherapy followed by a 1–2 year fellowship in stereotactic radiosurgery as the dedicated training most relevant to this technology. The guide also identifies four warning signs: recommending CyberKnife without confirming candidacy, no named medical physicist, vague treatment volume and quoting a price before imaging is reviewed.
• The page 4 cost chart gives illustrative private costs of approximately C$9,000 in India, C$17,000 in Thailand, C$26,000 in Singapore, C$42,000 in Canada and C$110,000 in the United States for a standard five-session stereotactic body radiotherapy course. The guide notes that actual costs vary according to tumour location and recommends an itemised quotation.

Quick Facts

Treatment

CyberKnife Stereotactic Radiosurgery

Patients

Canadian Patients

Key Specialist

Radiation Oncologist

Selection Weighting

55% treating team / 45% hospital

Key Qualification

MD Radiotherapy + Stereotactic Radiosurgery Fellowship

Key Technology

Real-time tumour tracking & sub-millimetre precision

Team Check

Named Medical Physicist

Hospital Check

Multidisciplinary Tumour Board & Accreditation

Typical Sessions

Approximately 5

India Cost

Approximately C$9,000

Canada Cost

Approximately C$42,000

US Cost

Approximately C$110,000

Pre-Travel Records

Full imaging & pathology

Follow-Up

Canadian oncology team & follow-up imaging

Key Warning

Avoid centres that recommend CyberKnife without reviewing your specific case

Decision Principle

Prioritise genuine candidacy, established treatment volume and qualified medical physics support.

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

For Canadian patients, the guide's central message is to confirm genuine CyberKnife candidacy before choosing a centre and then assess the treating team, medical physics support, treatment volume, accreditation, cost and follow-up. The guide also recommends arranging follow-up imaging and Canadian oncology review before leaving India.

CyberKnife is a genuinely remarkable technology, delivering precise, high-dose radiation without surgery in far fewer sessions than conventional radiotherapy. This guide exists for patients whose radiation oncologist has confirmed they're a genuine candidate, weighing where that treatment should happen.

This matters directly for Canadian patients today: even where a business case has been approved, building genuine day-to-day operational experience with a new system takes years, meaning a newly commissioned Canadian CyberKnife programme may not yet have accumulated the kind of deep, routine treatment volume that an established international programme has built over a much longer operating history.

For patients facing this genuine, documented scarcity, the case for looking seriously at India is a strong one: internationally accredited cancer centres with genuinely established radiosurgery volume, dedicated medical physics teams, and treatment that can typically begin within two to three weeks of your first consultation, all at a fraction of the equivalent Canadian private cost. This isn't a fallback option; for patients who understand exactly how limited domestic access remains, it's a considered, well-evidenced alternative worth exploring seriously.

Why this technology genuinely changes the treatment timeline

Get your full imaging and pathology together before your first overseas conversation. This is one of the most practically important distinctions to understand. Conventional radiotherapy typically spans several weeks of daily visits, a genuine burden for any patient, but particularly one who might otherwise need to travel repeatedly to one of Canada's few facilities offering this technology. CyberKnife's sub-millimetre precision and real-time tumour tracking allow a comparable effective dose to be delivered in around five sessions, a genuinely different commitment.

This session-count difference matters even more directly for patients considering travel specifically, since a five-session course is a fundamentally more manageable undertaking, whether travelling within Canada to one of the few domestic centres or considering treatment overseas, than committing to six weeks of daily visits at a facility far from home. For working patients, or those with family or caregiving responsibilities at home, the practical difference between a roughly one-week course and a six-week commitment is genuinely significant, often shaping the decision as much as the underlying clinical benefit of the technology itself.

Why India specifically, not just “overseas”

This is worth spelling out plainly, because “medical travel” can sound vague until you see what it actually means in practice. India's leading cancer centres operate CyberKnife and equivalent stereotactic systems as established, routine practice, with dedicated medical physics teams and genuine treatment volume that reflects the scale of the population these centres serve, a depth of experience genuinely difficult to build when a technology remains this rare domestically. This is not a compromise reached for cost and speed; it may currently be the more accessible, well-established path to this exact technology for many Canadian patients.

Real-time tumour tracking and sub-millimetre precision delivery are established, routine practice at India's leading centres, not occasional showcase equipment reserved for exceptional cases. Every consultation, medical record, consent discussion and follow-up letter happens in English, conducted by specialists trained to internationally recognised standards, and leading hospitals hold Joint Commission International accreditation alongside India's own NABH certification. Put together, this is genuinely comparable radiosurgery care, delivered by teams with considerably more established, ongoing experience with this exact technology, at a fraction of the price.

Ten weighted criteria, out of 100

The same weighting that applies across this series applies here: the treating team carries 55 points, the hospital 45. Part one, judging the team: an honest candidacy assessment for your specific tumour, a named medical physicist, genuine established treatment volume, and candid outcome data.

Part two, judging the hospital: genuinely established treatment volume, not a newly installed system, a real multidisciplinary tumour board, verified international accreditation, and a complete treatment record your Canadian oncology team can use.

Four Signals That Should Make You Pause

• CyberKnife recommended without discussing your specific candidacy. Not every tumour is a genuine candidate; ask directly why this technology suits your case.
• No named medical physicist. Ask who is specifically responsible for treatment planning and quality assurance.
• Vagueness about established treatment volume. Ask how long the centre has operated this system, and how many patients treated.
• A price quoted before your imaging has been reviewed. Nobody can meaningfully assess or price this treatment without seeing your specific case.

Canada-specific considerations most patients miss

Ask your Canadian radiation oncologist directly about domestic CyberKnife access. Given how limited it remains, a direct, honest answer about wait time and travel requirements is worth getting early.

Arrange your follow-up imaging before you leave. Confirm your Canadian team is willing to review results from treatment performed overseas. Results from radiosurgery typically take weeks to months to become fully apparent, so a clear, agreed monitoring schedule with your Canadian team matters considerably for tracking your response over time.

Tell your Canadian oncology team early, not after the fact. Most are more sympathetic to exploring every option than patients expect.

The Questions, in the Order You Should Ask Them

A closing word

CyberKnife remains a genuinely rare technology across Canada, with even its expansion to a second province explicitly noted as a milestone rather than routine progress, and provinces still formally studying whether a single dedicated unit is justified. For patients confirmed as genuine candidates, the case for India is genuinely strong, not a fallback option: radiosurgery centres with established, genuine treatment volume and technology in routine daily use, and treatment that can typically begin within two to three weeks, at a fraction of the equivalent Canadian private cost.

In 24 years of guiding patients through exactly this decision, the pattern is consistent: those who look closely at what India's leading radiosurgery centres actually offer, rather than assuming distance means compromise, generally come away reassured rather than anxious. Confirm genuine candidacy first, insist on a named medical physicist and established treatment volume, and travel with a written, itemised quote in hand.

If you would like a second opinion on your imaging, send it and I will look at it properly.

Frequently Asked Questions by Canadians about CyberKnife Treatment Centres in India

Why is CyberKnife access limited in Canada?

The guide explains that CyberKnife requires a multi-million-dollar system, specialised medical physics staff, planning software and ongoing maintenance, making it difficult for smaller health systems to justify and operate.

How many CyberKnife sessions may be required?

The guide's page 2 graphic compares approximately 5 CyberKnife sessions with around 30 conventional radiotherapy sessions, although the actual schedule depends on the patient's condition and treatment plan.

Is every tumour suitable for CyberKnife?

No. The guide specifically warns against centres that recommend CyberKnife without discussing whether the patient's specific tumour is genuinely suitable.

What specialist should I look for?

Look for a radiation oncologist with specific stereotactic radiosurgery experience and dedicated training in the technology.

What qualification is highlighted?

The guide identifies MD in Radiotherapy followed by a 1–2 year fellowship in stereotactic radiosurgery as particularly relevant.

Why is a medical physicist important?

A named medical physicist should be responsible for treatment planning and quality assurance. The guide considers the absence of a named physicist a warning sign.

How much does CyberKnife treatment cost in India?

The guide gives an illustrative cost of approximately C$9,000 in India, compared with C$42,000 in Canada and C$110,000 in the US.

What should I provide before travelling?

Send your complete imaging and pathology before the overseas consultation so the treating team can assess CyberKnife suitability.

What should I ask the centre?

Ask whether you are genuinely suitable, who the named medical physicist is, how long the CyberKnife programme has operated, how many patients have been treated and what outcomes have been achieved for similar tumours.

What should I arrange after treatment?

Arrange follow-up imaging and Canadian oncology review before leaving India. The guide notes that radiosurgery results can take weeks to months to become fully apparent, making an agreed monitoring schedule important.

Sources

• Ontario Introduces CyberKnife Robotic Radiosurgery at Juravinski Cancer Centre, Cancer Care Ontario announcement — newswire.ca
• Cost Estimation of Stereotactic Radiosurgery Technologies, Alberta Health Technology Assessment — database.inahta.org
• National Medical Commission — nmc.org.in
• National Accreditation Board for Hospitals & Healthcare Providers — nabh.co

Page Summary

This guide helps Canadian patients compare CyberKnife treatment centres in India, focusing on candidacy, treatment experience, medical physics, technology, hospital accreditation, cost and follow-up. It highlights the limited availability of CyberKnife in Canada and the shorter treatment course of approximately 5 sessions versus around 30 conventional radiotherapy sessions. Indicative costs are C$9,000 in India, C$42,000 in Canada and C$110,000 in the US.

Citation Block

Field	Information
Topic	Best CyberKnife Treatment Centres in India for Canadian Patients
Treatment	CyberKnife / Stereotactic Radiosurgery
Patients	Canadian Patients
Specialist	Radiation Oncologist
Selection Weighting	55% treating team / 45% hospital
Key Qualification	MD Radiotherapy + Stereotactic Radiosurgery Fellowship
Candidacy Check	Confirm tumour is suitable for CyberKnife
Team Check	Named medical physicist & established treatment volume
Technology Check	Real-time tumour tracking & sub-millimetre precision
Hospital Check	Tumour board & international accreditation
Typical Sessions	~5 sessions
India Cost	~C$9,000
Canada Cost	~C$42,000
US Cost	~C$110,000
Records Required	Imaging & pathology
Follow-Up	Canadian oncology team & follow-up imaging
Warning Signs	No candidacy review, no named physicist, vague volume, early pricing
Patient Pathway	Imaging/pathology → consultation → quote → planning → CyberKnife → follow-up scans
Key Decision	Prioritise appropriate candidacy, established expertise and medical physics support